Education
About Us
Working with TipRanks
Follow Us
Nadja West Insider Profile
11 Followers
Nadja West, Director at Tenet Healthcare, holds 28.48K shares in Tenet Healthcare (Ticker: THC), holds 9.95K shares in Nucor (Ticker: NUE), holds ― shares in Johnson & Johnson (Ticker: JNJ). Most recently, Nadja West Sold ― shares of Tenet Healthcare on Dec 17, 2025 for an estimated value of $430.09K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+150.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Nadja West holds in companies
Most Profitable Insider Trade
The most profitable trade made by Nadja West
Nadja West's Trading History
Tenet Healthcare
Dec 17, 2025
Director
Informative Sell
430.09K
$5.55M
Nucor
Jun 03, 2025
Director
Uninformative Buy
―
$1.60M
Johnson & Johnson
―
Director
―
―
Tempus AI, Inc. Class A
May 22, 2025
Director
Uninformative Buy
―
$2.07M
List of latest transactions for each holding click on a transaction to see Nadja West's performance on stock
You May Also Like
Nadja West insider profile FAQ
What is the percentage of profitable transactions made by Nadja West?
The percentage of profitable transactions made by Nadja West is 50%.
What is the average return per transaction made by Nadja West?
The average return per transaction made by Nadja West is 150.00%.
What stocks does Nadja West hold?
Nadja West holds: THC, NUE, JNJ, TEM stocks.
What was Nadja West’s latest transaction?
Nadja West latest transaction was an Informative Sell of $430.09K.
What was Nadja West's most profitable transaction?
Nadja West’s most profitable transaction was an Informative Buy of THC stock on March 17, 2020. The return on the trade was 317.00%.
What is Nadja West's role in Tenet Healthcare?
Nadja West's role in Tenet Healthcare is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.